Gilead Sciences, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionAxa S.a.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Axa S.a. closes position in GILD / Gilead Sciences, Inc.

On November 14, 2025 - Axa S.a. filed a 13F-HR form disclosing ownership of 0 shares of Gilead Sciences, Inc. (US:GILD) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 14, 2025 disclosing 1,602,225 shares of Gilead Sciences, Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F GILEAD SCIENCES COM 375558103 0 -100.00 0
2025-08-14 2025-06-30 13F GILEAD SCIENCES COM 375558103 1,602,225 -2,264 -0.14 177,639 -1.19 0.5103
2025-05-15 2025-03-31 13F GILEAD SCIENCES COM 375558103 1,604,489 -195,568 -10.86 179,783 8.13 0.5905
2025-02-14 2024-12-31 13F GILEAD SCIENCES COM 375558103 1,800,057 201,769 12.62 166,271 24.08 0.5051
2024-11-14 2024-09-30 13F GILEAD SCIENCES COM 375558103 1,598,288 -147,593 -8.45 134,000 11.87 0.3968
2025-02-25 2024-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 1,745,881 -193,526 -9.98 119,785 -15.68 0.3563
2024-08-14 2024-06-30 13F GILEAD SCIENCES COM 375558103 1,745,881 -193,526 119,785 0.3563
2024-05-15 2024-03-31 13F GILEAD SCIENCES COM 375558103 1,939,407 127,661 7.05 142,062 -3.21 0.4258
2024-07-16 2023-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 1,811,746 64,985 3.72 146,770 12.12 0.4732
2024-02-14 2023-12-31 13F GILEAD SCIENCES COM 375558103 1,811,746 64,985 146,770 0.2874
2023-11-14 2023-09-30 13F GILEAD SCIENCES COM 375558103 1,746,761 85,819 5.17 130,902 2.26 0.4601
2023-08-14 2023-06-30 13F GILEAD SCIENCES COM 375558103 1,660,942 -180,360 -9.80 128,009 -16.21 0.4254
2023-05-15 2023-03-31 13F GILEAD SCIENCES COM 375558103 1,841,302 660,135 55.89 152,773 50.66 0.5255
2023-02-14 2022-12-31 13F GILEAD SCIENCES COM 375558103 1,181,167 -297,313 -20.11 101,403 11.18 0.3659
2023-02-14 2022-09-30 13F/A-1 Gilead Sciences COM 375558103 1,478,480 -366,793 -19.88 91,207 -20.03 0.3588
2022-11-14 2022-09-30 13F Gilead Sciences COM 375558103 1,478,480 -366,793 91,207 0.3588
2023-02-14 2022-06-30 13F/A-1 Gilead Sciences COM 375558103 1,845,273 -163,453 -8.14 114,056 -4.49 0.4227
2022-08-15 2022-06-30 13F Gilead Sciences COM 375558103 1,845,273 -163,453 114,056 0.4227
2023-02-14 2022-03-31 13F/A-1 Gilead Sciences COM 375558103 2,008,726 -45,795 -2.23 119,419 -19.95 0.3394
2022-05-13 2022-03-31 13F Gilead Sciences COM 375558103 2,008,726 -45,795 119,419 0.3394
2022-02-14 2021-12-31 13F Gilead Sciences COM 375558103 2,054,521 168,312 8.92 149,179 13.23 0.3813
2021-11-15 2021-09-30 13F Gilead Sciences COM 375558103 1,886,209 492,818 35.37 131,752 37.31 0.3697
2021-08-13 2021-06-30 13F/A-1 Gilead Sciences COM 375558103 1,393,391 416,188 42.59 95,949 51.92 0.2705
2021-08-13 2021-06-30 13F Gilead Sciences COM 375558103 1,393,391 416,188 95,949 0.1620
2021-05-14 2021-03-31 13F Gilead Sciences COM 375558103 977,203 -64,943 -6.23 63,157 4.02 0.1923
2021-02-12 2020-12-31 13F Gilead Sciences COM 375558103 1,042,146 -3,229 -0.31 60,716 -8.09 0.1906
2021-02-11 2020-09-30 13F/A-1 Gilead Sciences COM 375558103 1,045,375 -214,033 -16.99 66,057 -31.83 0.2387
2020-11-13 2020-09-30 13F Gilead Sciences COM 375558103 1,045,375 -214,033 66,057 238,743.2988
2021-02-12 2020-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 1,259,408 -13,928 -1.09 96,900 1.79 0.3818
2020-08-14 2020-06-30 13F GILEAD SCIENCES COM 375558103 1,259,408 -13,928 96,900 382,139.2907
2021-02-12 2020-03-31 13F/A-2 GILEAD SCIENCES COM 375558103 1,273,336 -152,844 -10.72 95,194 2.72 0.4758
2020-06-15 2020-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 1,273,336 0 95,194 0.4761
2020-05-15 2020-03-31 13F GILEAD SCIENCES COM 375558103 1,273,336 -152,844 95,194 264,736.1513
2021-02-12 2019-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 1,426,180 -200,196 -12.31 92,673 -10.10 0.3769
2020-02-18 2019-12-31 13F GILEAD SCIENCES COM 375558103 1,426,180 -200,196 92,673 377,332.7700
2021-02-12 2019-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 1,626,376 -79,561 -4.66 103,080 -10.56 0.4102
2019-11-14 2019-09-30 13F GILEAD SCIENCES COM 375558103 1,626,376 -79,561 103,080 410,780.3623
2021-02-12 2019-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 1,705,937 47,922 2.89 115,253 6.93 0.4499
2019-08-13 2019-06-30 13F GILEAD SCIENCES COM 375558103 1,705,937 47,922 115,253 451,973.7897
2019-05-14 2019-03-31 13F GILEAD SCIENCES COM 375558103 1,658,015 851,198 105.50 107,788 113.59 0.4212
2019-02-13 2018-12-31 13F GILEAD SCIENCES COM 375558103 806,817 -80,241 -9.05 50,466 -26.32 0.2200
2018-11-08 2018-09-30 13F GILEAD SCIENCES COM 375558103 887,058 100,458 12.77 68,490 22.91 0.2512
2018-08-13 2018-06-30 13F GILEAD SCIENCES COM 375558103 786,600 -22,724 -2.81 55,722 -8.67 0.2136
2018-05-14 2018-03-31 13F GILEAD SCIENCES COM 375558103 809,324 -524,306 -39.31 61,015 -36.14 0.2435
2018-02-13 2017-12-31 13F GILEAD SCIENCES COM 375558103 1,333,630 -1,465,253 -52.35 95,542 -57.87 0.3752
2017-12-01 2017-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 2,798,883 -288,922 -9.36 226,766 3.76 0.9769
2017-11-13 2017-09-30 13F GILEAD SCIENCES COM 375558103 2,798,883 -288,922 226,766
2017-08-10 2017-06-30 13F GILEAD SCIENCES COM 375558103 3,087,805 -564,456 -15.45 218,555 -11.90 0.9922
2017-05-11 2017-03-31 13F GILEAD SCIENCES COM 375558103 3,652,261 -300,659 -7.61 248,062 -12.37 1.1199
2017-02-13 2016-12-31 13F GILEAD SCIENCES COM 375558103 3,952,920 -65,871 -1.64 283,068 -10.98 1.3282
2016-11-10 2016-09-30 13F GILEAD SCIENCES COM 375558103 4,018,791 131,208 3.38 317,967 -1.95 1.3968
2016-08-11 2016-06-30 13F GILEAD SCIENCES COM 375558103 3,887,583 -281,656 -6.76 324,303 -15.32 1.4448
2016-05-13 2016-03-31 13F GILEAD SCIENCES COM 375558103 4,169,239 -202,142 -4.62 382,986 -13.42 1.7180
2016-02-12 2015-12-31 13F GILEAD SCIENCES COM 375558103 4,371,381 -173,452 -3.82 442,340 -0.88 1.9330
2015-11-13 2015-09-30 13F GILEAD SCIENCES COM 375558103 4,544,833 26,542 0.59 446,257 -15.64 1.8297
2015-08-13 2015-06-30 13F GILEAD SCIENCES COM 375558103 4,518,291 106,833 2.42 529,001 22.20 2.1176
2015-05-13 2015-03-31 13F GILEAD SCIENCES COM 375558103 4,411,458 513,928 13.19 432,896 17.83 1.7841
2015-02-13 2014-12-31 13F GILEAD SCIENCES COM 375558103 3,897,530 212,919 5.78 367,381 -6.33 1.4738
2014-11-13 2014-09-30 13F GILEAD SCIENCES COM 375558103 3,684,611 -282,012 -7.11 392,227 19.26 1.6768
2014-08-13 2014-06-30 13F GILEAD SCIENCES COM 375558103 3,966,623 1,463,021 58.44 328,873 85.38 1.3683
2014-05-13 2014-03-31 13F GILEAD SCIENCES COM 375558103 2,503,602 921,616 58.26 177,405 49.22 0.7717
2014-02-13 2013-12-31 13F GILEAD SCIENCES COM 375558103 1,581,986 1,702 0.11 118,886 19.72 0.5323
2013-11-13 2013-09-30 13F GILEAD SCIENCES COM 375558103 1,580,284 100,599 6.80 99,305 31.05 0.4891
2013-08-12 2013-06-30 13F GILEAD SCIENCES COM 375558103 1,479,685 1,479,685 75,775 0.4025
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.